Evidence map›Paper›PMID 31558672›Full record

ArticleHaematologica2020

D' domain region Arg782-Cys799 of von Willebrand factor contributes to factor VIII binding.

Małgorzata A Przeradzka, Josse van Galen, Eduard H T M Ebberink, Arie J Hoogendijk, Carmen van der Zwaan, Koen Mertens, Maartje van den Biggelaar, Alexander B Meijer

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. A Novel GeneticTransfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Małgorzata A PrzeradzkaDepartment of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam.
Josse van GalenDepartment of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam.
Eduard H T M EbberinkDepartment of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam.
Arie J HoogendijkDepartment of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam.
Carmen van der ZwaanDepartment of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam.
Koen MertensDepartment of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam.
Maartje van den BiggelaarDepartment of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam.
Alexander B MeijerDepartment of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam s.meijer@sanquin.nl.
Sanquin · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the complex with von Willebrand factor (VWF) factor VIII (FVIII) is protected from rapid clearance from circulation. Although it has been established that the FVIII binding site resides in the N-terminal D'-D3 domains of VWF, detailed information about the amino acid regions that contribute to FVIII binding is still lacking. In the present study, hydrogen-deuterium exchange mass spectrometry was employed to gain insight into the FVIII binding region on VWF. To this end, time-dependent deuterium incorporation was assessed in D'-D3 and the FVIII-D'-D3 complex. Data showed reduced deuterium incorporation in the D' region Arg782-Cys799 in the FVIII-D'-D3 complex compared to D'-D3. This implies that this region interacts with FVIII. Site-directed mutagenesis of the six charged amino acids in Arg782-Cys799 into alanine residues followed by surface plasmon resonance analysis and solid phase binding studies revealed that replacement of Asp796 affected FVIII binding. A marked decrease in FVIII binding was observed for the D'-D3 Glu787Ala variant. The same was observed for D'-D3 variants in which Asp796 and Glu787 were replaced by Asn796 and Gln787. Site-directed mutagenesis of Leu786, which together with Glu787 and Cys789 forms a short helical region in the crystal structure of D'-D3, also had a marked impact on FVIII binding. The combined results show that the amino acid region Arg782-Cys799 is part of a FVIII binding surface. Our study provides new insight into FVIII-VWF complex formation and defects therein that may be associated with bleeding caused by markedly reduced levels of FVIII.

Indexed as

Factor VIIIvon Willebrand FactorBinding SitesHemorrhageHumansProtein DomainsFactor VIIIvon Willebrand Factor

Identifiers

PMID31558672
PMCPMC7271574
OpenAlexW2976309747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.